Publications by authors named "Uwe Ligges"
It was the aim of this study to examine whether the usage of the vaccine COXEVAC (Ceva Santé Animale) could reduce the consumption of antibiotics in Q-fever-positive dairy farms. Additionally, the effects of other herd-level factors on the consumption of antibiotics were investigated. A total of 36 farms with vaccination and 13 farms without vaccination participated in this longitudinal cohort study.
View Article and Find Full Text PDFEvidence of the medical and economic benefits of implementing hygiene measures by a prevention link physician in trauma surgery: Study protocol for a biphasic multicenter prospective interventional pre-post cohort study using a structured intervention bundle development and tools of behavior change management.
Contemp Clin Trials Commun
September 2021
Introduction: The German Commission for Hospital Hygiene and Infection Prevention recommends nominating one authorized medical specialist in every medical department as an infection prevention link physician (PLP). It has been roughly described that a PLP serves as a link between the infection prevention team and the respective clinical departments. No detailed evidence about the contribution made by PLPs to the decrease of infection rates is available in Germany.
View Article and Find Full Text PDFBlood pressure control in patients with type 2 diabetes and hypertension is poor. It is unclear how effectively general practitioners assess and treat such patients. T2Target included hypertensive patients with type 2 diabetes mellitus who had undergone ambulatory blood pressure monitoring within the past 3 months.
View Article and Find Full Text PDFPurpose: The objective of this study was to assess whether CCDS might improve the outcome of testicular sperm retrieval in patients with azoospermia. Furthermore, we evaluated potential sonographic alterations of the testis before and after trifocal and Micro-TESE.
Methods: 78 patients were enrolled prospectively: 24 with obstructive azoospermia (OA) and 54 with non-obstructive azoospermia (NOA).
Article Synopsis
- The study looks at what happens to patients with prostate cancer when they stop taking a drug called enzalutamide.
- They found that none of the 31 patients had lower levels of a blood marker (PSA) after stopping the drug, and instead, most had higher levels.
- The researchers think that certain features of enzalutamide might mean that a withdrawal syndrome, if it exists, is very rare and might need more time to notice in the future.